UDC & LCC PARTNERS IN CANCER RES TRAIN ED & OUTREACH

UDC

基本信息

  • 批准号:
    6515108
  • 负责人:
  • 金额:
    $ 18.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-05-15 至 2004-04-30
  • 项目状态:
    已结题

项目摘要

The annual age-adjusted mortality rate for cancer in the District of Columbia (DC) is 212 per 100,000 persons, compared to 170 for the Nation. The incidence of cancer is disproportionately high among African Americans, who constitute 68% of the population of the District of Columbia. DC exemplifies that cancer rate disparities exist among different racial groups. In an attempt to address the cancer burden among the African American community in general, and that of DC in particular, we will establish a partnership between the Lombardi Cancer Center (LCC), which is a comprehensive Cancer Center (CCC), and the University of the District of Columbia (UDC), which is a minority serving institution (MSI). The aims proposed below are critically needed in the District because of its high cancer burden, and this P20 planning grant is an ideal mechanism for fostering our partnership and achieving our objectives: (1). To foster a long term cancer research focus at UDC, along with collaborative relationships with LCC, by training two research faculty from UDC in cancer research; (2) To develop a joint long-lived undergraduate training program in cancer biology and cancer prevention, consisting of at least 2 undergraduate courses and a senior research project program, in order to encourage minorities to apply to graduate cancer research programs; (3) To increase the awareness and promote research at LCC relating to cancer and cancer disparities among the D.C. African American community. (4). To develop a joint long-lived cancer outreach program focusing on cancer prevention and risk behavior in the African American community. This planning grant was deliberately designed to consist of a realistic beginning for the partnership, where there was none before. It addresses clear gaps in the respective institutions and the needs in the local community.
哥伦比亚特区每年的年龄调整癌症死亡率为每10万人212人,而全国为每10万人170人。非裔美国人的癌症发病率高得不成比例,他们占哥伦比亚特区人口的68%。DC举例说明了不同种族群体之间癌症发病率的差异。为了解决整个非裔美国人社区,特别是华盛顿特区的癌症负担,我们将在综合性癌症中心伦巴第癌症中心(LCC)和哥伦比亚特区大学(UDC)之间建立伙伴关系,后者是少数族裔服务机构(MSI)。由于癌症负担高,该地区急需以下建议的目标,而这项P20规划补助金是促进我们的伙伴关系和实现我们目标的理想机制:(1)。通过培训UDC的两名研究人员从事癌症研究,培养UDC长期的癌症研究重点,以及与LCC的合作关系;(2)联合制定癌症生物学和癌症预防的长期本科培养计划,包括至少2门本科课程和一个高级研究项目计划,以鼓励少数民族申请研究生癌症研究计划;(3)提高对华盛顿特区非裔美国人社区癌症和癌症差异的认识并促进LCC的研究。(4). 在非裔美国人社区开展长期癌症联合推广项目,重点关注癌症预防和风险行为。这一规划赠款是有意设计为伙伴关系提供一个现实的开端,这是以前没有的。它解决了各自机构的明显差距和当地社区的需求。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NORMAN S KONDO其他文献

NORMAN S KONDO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NORMAN S KONDO', 18)}}的其他基金

UDC & LCC PARTNERS IN CANCER RES TRAIN ED & OUTREACH
UDC
  • 批准号:
    6634056
  • 财政年份:
    2001
  • 资助金额:
    $ 18.92万
  • 项目类别:
UDC & LCC PARTNERS IN CANCER RES TRAIN ED & OUTREACH
UDC
  • 批准号:
    6335858
  • 财政年份:
    2001
  • 资助金额:
    $ 18.92万
  • 项目类别:
STUDIES ON OLIGONUCLEOTIDES CONTAINING POSITIVELY CHARGED BASES
含正电荷碱基寡核苷酸的研究
  • 批准号:
    6204070
  • 财政年份:
    1999
  • 资助金额:
    $ 18.92万
  • 项目类别:
STUDIES ON OLIGONUCLEOTIDES CONTAINING POSITIVELY CHARGED BASES
含正电荷碱基寡核苷酸的研究
  • 批准号:
    6107003
  • 财政年份:
    1998
  • 资助金额:
    $ 18.92万
  • 项目类别:
STUDIES ON OLIGONUCLEOTIDES CONTAINING POSITIVELY CHARGED BASES
含正电荷碱基寡核苷酸的研究
  • 批准号:
    6239889
  • 财政年份:
    1997
  • 资助金额:
    $ 18.92万
  • 项目类别:
CROSS-LINKED ANTIGENE OLIGOMERS EFFECT ON TRANSCRIPTION
交联抗原寡聚物对转录的影响
  • 批准号:
    6179222
  • 财政年份:
    1996
  • 资助金额:
    $ 18.92万
  • 项目类别:
CROSS-LINKED ANTIGENE OLIGOMERS EFFECT ON TRANSCRIPTION
交联抗原寡聚物对转录的影响
  • 批准号:
    2734311
  • 财政年份:
    1996
  • 资助金额:
    $ 18.92万
  • 项目类别:
CROSS-LINKED ANTIGENE OLIGOMERS EFFECT ON TRANSCRIPTION
交联抗原寡聚物对转录的影响
  • 批准号:
    2166031
  • 财政年份:
    1996
  • 资助金额:
    $ 18.92万
  • 项目类别:
CROSS-LINKED ANTIGENE OLIGOMERS EFFECT ON TRANSCRIPTION
交联抗原寡聚物对转录的影响
  • 批准号:
    6018250
  • 财政年份:
    1996
  • 资助金额:
    $ 18.92万
  • 项目类别:
CROSS-LINKED ANTIGENE OLIGOMERS EFFECT ON TRANSCRIPTION
交联抗原寡聚物对转录的影响
  • 批准号:
    2444413
  • 财政年份:
    1996
  • 资助金额:
    $ 18.92万
  • 项目类别:

相似海外基金

Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador
制定 HPV 耻辱评估量表和减少耻辱干预措施,以改善萨尔瓦多的宫颈癌预防
  • 批准号:
    10844859
  • 财政年份:
    2023
  • 资助金额:
    $ 18.92万
  • 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
  • 批准号:
    10829054
  • 财政年份:
    2023
  • 资助金额:
    $ 18.92万
  • 项目类别:
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
  • 批准号:
    10763054
  • 财政年份:
    2023
  • 资助金额:
    $ 18.92万
  • 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
  • 批准号:
    10758129
  • 财政年份:
    2023
  • 资助金额:
    $ 18.92万
  • 项目类别:
TOPIC 453: THE PERFECT MEDICAL ASSISTANT FOR CANCER PREVENTION WITHIN PRIMARY CARE
主题 453:初级保健中预防癌症的完美医疗助手
  • 批准号:
    10931123
  • 财政年份:
    2023
  • 资助金额:
    $ 18.92万
  • 项目类别:
Co-creating a community engagement knowledge translation summit on improving cancer prevention and screening in Canada
共同创建社区参与知识翻译峰会,以改善加拿大的癌症预防和筛查
  • 批准号:
    480839
  • 财政年份:
    2023
  • 资助金额:
    $ 18.92万
  • 项目类别:
    Miscellaneous Programs
PIECES – Towards Large-Scale Adaption and Tailored Implementation of Evidence-Based Primary Cancer Prevention Programmes in Europe and Beyond
部分内容 — 致力于在欧洲及其他地区大规模适应和定制实施循证初级癌症预防计划
  • 批准号:
    10079747
  • 财政年份:
    2023
  • 资助金额:
    $ 18.92万
  • 项目类别:
    EU-Funded
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
  • 批准号:
    10737017
  • 财政年份:
    2023
  • 资助金额:
    $ 18.92万
  • 项目类别:
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
乌干达宫颈癌预防游戏规则改变者的混合实施-有效性试验
  • 批准号:
    10718609
  • 财政年份:
    2023
  • 资助金额:
    $ 18.92万
  • 项目类别:
Using mHealth to investigate intersectionality and health behaviors: Implications for conceptual models and cancer prevention interventions for marginalized populations
使用移动医疗研究交叉性和健康行为:对边缘化人群的概念模型和癌症预防干预措施的影响
  • 批准号:
    10746886
  • 财政年份:
    2023
  • 资助金额:
    $ 18.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了